PFE News and Press, Pfizer Inc.

2024-05-15 11:40:47 ET The temperament on Wall Street is mixed at the moment, split between analysts believing that the next leg up in a bull market is set to take place and others forecasting a bearish move lurking around the corner. For investors looking for more safety, dividend picks ca...

2024-05-15 08:45:36 ET Summary Pfizer has been a losing investment for several years, but stronger trading momentum is starting to appear. An easily covered and safety-minded 6% dividend yield is very attractive today. Undervaluation arguments to own shares also exist. PFE sto...

2024-05-14 10:07:00 ET Your long-term investment portfolio should have meaningful exposure to healthcare stocks . People will always seek treatments for disease, so demand for the sector won't go away any time soon. Moreover, there's a wide variety of healthcare companies, making it an ...

2024-05-14 08:10:00 ET Summary Portfolio changes in April focus on BDCs, aiming to increase dividend income by at least $100 each month. Dividend income hit a new all-time record for April of $736, basically flat Y/Y and up 12% sequentially. Gifted Working Time 2024: Around 85...

2024-05-13 13:53:13 ET More on AstraZeneca, Pfizer Pfizer's Bottom May Be Here - Its Rich Yield Is Tempting Pfizer: A 6% Yield And At 10-Year Lows Pfizer Stock: Not A Value Trap, Here's Why Pfizer to settle over 10,000 Zantac-related cancer claims: report ...

2024-05-13 13:24:17 ET More on Corbus Pharmaceuticals Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals Historical earnings data for Corbus Pharmaceuticals Financial i...

2024-05-13 12:07:12 ET Summary First Trust Morningstar Dividend Leaders Index Fund ETF holds 90 stocks of companies with higher yields and 5-year dividend growth. The FDL ETF is well diversified across sectors, but quite concentrated in financials and its top holdings. FDL is ...

Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting PR Newswire 16 abstracts feature new data and post-hoc analyses of pivotal trials across several types of hard-to-treat cancers TOKYO , May 13, 2024 /PRNe...

2024-05-13 06:27:24 ET Pfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. However, recent developments suggest a potential turnaround for the pharmaceutical giant. On May 1, 2024, Pfizer reported better-than-exp...

2024-05-13 03:07:00 ET Pfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its dividend payout, meanwhile, has continued to rise again and again. This combination has pushed the dividend yield up to nearly 6%. Is this your chance to secure ...